基本信息
views: 122
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Prof. Jamie Rossjohn’s research is centred on an understanding immunity. He is currently a NHMRC Investigator L3 Fellow (2022-26) and previously an ARC Australian Laureate Fellow (2017-21), NHMRC Australia Fellow (2011-16) and ARC Federation Fellow (2007-11). He was the former Head of the Infection and Immunity Program (2016-19) of the Biomedicine Discovery Institute. In 2022, Prof. Rossjohn was elected as a Fellow of the Royal Society and Associate Member of EMBO.
Prof. Rossjohn is known for his contributions to the understanding the molecular basis underpinning immunity. He has used structural biology to explain pre-T- cell receptor (TCR) self-association in T-cell development, and how the TCR specifically recognises polymorphic Human Leukocyte Antigen (HLA) molecules in the context of viral immunity and aberrant T- cell reactivity.
He has unearthed structural mechanisms of HLA polymorphism impacting on drug and food hypersensitivities, as well as Natural Killer cell receptor recognition. He has pioneered our molecular understanding of lipid-based immunity by T cells, revealing that it can differ fundamentally from peptide-mediated adaptive immunity.
Recently he has provided a structural basis of how vitamin B metabolites can be presented and recognised by the immune system, revealing a new class of antigen. Collectively, he has published > 465 papers and mentored numerous researchers towards obtaining higher degrees and nationally competitive fellowships.
Prof. Rossjohn is known for his contributions to the understanding the molecular basis underpinning immunity. He has used structural biology to explain pre-T- cell receptor (TCR) self-association in T-cell development, and how the TCR specifically recognises polymorphic Human Leukocyte Antigen (HLA) molecules in the context of viral immunity and aberrant T- cell reactivity.
He has unearthed structural mechanisms of HLA polymorphism impacting on drug and food hypersensitivities, as well as Natural Killer cell receptor recognition. He has pioneered our molecular understanding of lipid-based immunity by T cells, revealing that it can differ fundamentally from peptide-mediated adaptive immunity.
Recently he has provided a structural basis of how vitamin B metabolites can be presented and recognised by the immune system, revealing a new class of antigen. Collectively, he has published > 465 papers and mentored numerous researchers towards obtaining higher degrees and nationally competitive fellowships.
Research Interests
Papers共 877 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FEBS JOURNALno. 7 (2024): 1530-1544
ISCIENCEno. 2 (2024): 108801-108801
bioRxiv : the preprint server for biology (2024)
Journal of Biological Chemistryno. 5 (2024): 107229-107229
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 9 (2024): e2315985121-e2315985121
Emi Ito,Shinsuke Inuki,Yoshihiro Izumi,Masatomo Takahashi, Yuki Dambayashi,Lisa Ciacchi,Wael Awad, Ami Takeyama,Kensuke Shibata,Shotaro Mori,Jeffrey Y W Mak,David P Fairlie,
Science immunologyno. 91 (2024): eade6924-eade6924
Immunology and cell biologyno. 5 (2024): 321-325
Cellno. 14 (2024): 3496-3501
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn